Founded in 2018 in Canada, Bay Pharma is a pharmaceutical company committed to improving patient access to high-quality and innovative medicines worldwide. As a licensed pharmaceutical establishment holding a Drug Establishment Licence (DEL) issued by Health Canada, we operate in full compliance with stringent Canadian standards.

Today, Bay Pharma is a trusted partner of pharmaceutical manufacturers across the globe, supporting product registration, commercialization, and strategic marketing activities in Canada and key Asian markets. Through our extensive industry network and regulatory expertise, we help bring high-quality pharmaceutical products to patients efficiently and sustainably.

Innovation remains at the heart of our growth strategy. We continuously invest in research and development, actively exploring new products and therapeutic opportunities to address evolving healthcare needs. Our commitment to innovation has resulted in a robust pipeline of more than 30 internally R&D products, reflecting our dedication to delivering effective and accessible treatment options to patients worldwide.

At Bay Pharma, we strive to bridge global pharmaceutical innovation with local healthcare needs, creating long-term value for patients, healthcare professionals, and business partners alike.